Announcements Trials
Browse Landscape

Status

Approved for marketing 1

Sponsor Class

OTHER 1

Study Type

Observational 5Expanded_access 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 14Colorectal Neoplasms 9Carcinoma, Hepatocellular 9Gastrointestinal Stromal Tumors 7Carcinoma, Non-Small-Cell Lung 7Stomach Neoplasms 6Ovarian Neoplasms 6Liver Neoplasms 6Cholangiocarcinoma 6Prostatic Neoplasms 5Breast Neoplasms 5Melanoma 4Sarcoma 3Head and Neck Neoplasms 3Gastrointestinal Neoplasms 3Colonic Neoplasms 3Carcinoma, Squamous Cell 3Neuroblastoma 2Neoplasms 2Hepatoblastoma 2Glioblastoma 2Esophageal Neoplasms 2Endometrial Neoplasms 2Carcinoma, Renal Cell 2Wounds and Injuries 1Wilms Tumor 1Uveal Melanoma 1Uterine Neoplasms 1Urinary Bladder Neoplasms 1Thyroid Neoplasms 1

Interventions

Oxaliplatin 1Leucovorin 1Fluorouracil 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Expanded_access × Wounds and Injuries × Gastrointestinal × Clear all
NCT02436044 2019-08-20

HAIC Using Oxaliplatin Plus Fluorouracil/Leucovorin for Patients With Locally Advanced HCC

Sun Yat-sen University

Approved for marketing
Gastrointestinal

Carcinoma, Hepatocellular, Wounds and Injuries

Data powered by HemOnc (CC BY 4.0) Colophon âš¡